Descemet membrane endothelial keratoplasty
Descemet membrane endothelial keratoplasty is a medical procedure with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
2
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Impact of Donor Diabetes on DMEK Success and Endothelial Cell Loss
Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years
DMEK Endothelial Keratoplasty in Patients With a History of Anterior or Posterior Segment Surgery
Ripasudil for Enhanced Corneal Clearing Following Descemet Membrane Endothelial Keratoplasty in Fuchs' Dystrophy
Predictive Factors of Graft Detachment Following Dmek
Clinical Trials (6)
Impact of Donor Diabetes on DMEK Success and Endothelial Cell Loss
Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years
DMEK Endothelial Keratoplasty in Patients With a History of Anterior or Posterior Segment Surgery
Ripasudil for Enhanced Corneal Clearing Following Descemet Membrane Endothelial Keratoplasty in Fuchs' Dystrophy
Predictive Factors of Graft Detachment Following Dmek
Technique And Results In Endothelial Keratoplasty
All 6 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 6